rs794726772
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_001165963.4(SCN1A):c.2946+1G>T variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001165963.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN1A | ENST00000674923.1 | c.2946+1G>T | splice_donor_variant, intron_variant | Intron 18 of 28 | NM_001165963.4 | ENSP00000501589.1 | ||||
SCN1A | ENST00000303395.9 | c.2946+1G>T | splice_donor_variant, intron_variant | Intron 17 of 27 | 5 | ENSP00000303540.4 | ||||
SCN1A | ENST00000375405.7 | c.2913+1G>T | splice_donor_variant, intron_variant | Intron 15 of 25 | 5 | ENSP00000364554.3 | ||||
SCN1A | ENST00000409050.1 | c.2862+1G>T | splice_donor_variant, intron_variant | Intron 15 of 25 | 5 | ENSP00000386312.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Early infantile epileptic encephalopathy with suppression bursts Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Studies have shown that disruption of this splice site results in skipping of exon 15, but is expected to preserve the integrity of the reading-frame (PMID: 25590135). ClinVar contains an entry for this variant (Variation ID: 189935). Disruption of this splice site has been observed in individual(s) with clinical features of SCN1A-related conditions (PMID: 17347258). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change affects a donor splice site in intron 15 of the SCN1A gene. RNA analysis indicates that disruption of this splice site induces altered splicing and likely results in a shortened protein product. -
not provided Pathogenic:1
The c.2946+1 G>T splice site variant in the SCN1A gene has been previously reported as a de novo variant in a patient with febrile and generalized tonic-clonic seizures and myoclonic jerks beginning around 6 months of age (Harkin et al., 2007). This variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The c.2946+1 G>T variant destroys the canonical splice donor site in intron 15, and is expected to cause abnormal gene splicing. -
Severe myoclonic epilepsy in infancy Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at